Fenwal Receives FDA Approval

Lake Zurich-based Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced Tuesday that the U.S. Food and Drug Administration has granted Fenwal approval to market Interpol platelet additive solution.
Daily Herald